Company intelligence / Profile preview

Neurocognitive Therapeutics

Ownership: Private
Development stage: Other

Overview

Neurocognitive Therapeutics develops proprietary nutraceutical formulations aimed at enhancing cognition, supporting healthy aging, and addressing wellness factors related to neurodevelopmental and neurodegenerative conditions. The company markets blends for anti-aging, brain health, women's health, athletic performance/wellness, with future plans for pediatric/adolescent products. No clinical trial data or peer-reviewed results are referenced.

Therapeutic areas: PsychiatryNeurologyOther
Modalities: NutraceuticalPhytonutrient-based therapy
Industry: Food & Nutrition

Beyond the preview

Go deeper on Neurocognitive Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurocognitive Therapeutics.

Explore the full profile